Karnilev Solution

Levocarnitine has an anabolic effect, stimulates the secretion of gastric juice, slows down the breakdown of protein and carbohydrate molecules. Reduces excess body weight and reduces muscle fat.

Each 1 ml contains: L-carnitine – 100 mg;

excipients: malic acid, sodium methylparaben, sodium propylparaben, sodium saccharin, orange flavor, purified water.

secondary carnitine deficiency – congenital (organic aciduria), acquired alimentary carnitine deficiency (malabsorption, intestinal diseases), in patients receiving hemodialysis for a long time and having the following symptoms – severe persistent muscle spasms, myopathies, loss of muscle mass, skeletal muscle weakness, symptoms hypotension, anemia, impaired renal reabsorption (CRF)
impaired metabolism in the myocardium in the case of ischemic cardiomyopathy (in the myocardium, the utilization of fatty acids as an energy source occurs very intensively, therefore it especially needs L-carnitine, after its use, an increase in the force of contractions is noted, prevention of further muscle degeneration, normalization of the ECG)
angina pectoris, acute myocardial infarction, a state of severe hypoperfusion due to cardiogenic shock
damage to the central and peripheral nervous system, respiratory distress – syndrome, impaired psychomotor development, seizures, ataxia, pyramidal disorders, disorders of the oculomotor nerves (external ophthalmoplegia, ptosis, etc.)
polyneuropathy with liver damage (progressive hepatomegaly, liver fibrosis, liver failure phenomenon, kidney damage (Fanconi triad, phosphaturia, glucosuria, aminoacidizing), endocrine disorders (growth retardation, hypoglycemia), hearing impairment (sensorineural deafness), visual impairment ( optic atrophy, retinal pigment degeneration, cataract), gastrointestinal disorders
diseases and conditions accompanied by decreased appetite, weight loss, wasting in adults and children
anorexia nervosa syndrome (anorexia nervosa) and physical exhaustion in mental illness, dyscirculatory and traumatic encephalopathy
chronic pancreatitis with exocrine insufficiency
chronic gastritis with decreased secretory function
consequences of birth trauma and newborn asphyxiation
newborns, premature and term-born children with weakened food reflexes (flaccid sucking), with hypotrophy, hypotension and adynamia
respiratory distress syndrome in newborns, nursing premature newborns on complete parenteral nutrition
neonatal jaundice
during the period of convalescence after serious illnesses and surgical interventions;
growth retardation and underweight in children and adolescents under 16 years old, mild thyrotoxicosis in children and adolescents under 16 years old
as part of complex therapy for skin diseases (psoriasis, seborrheic eczema, focal scleroderma and discoid lupus erythematosus)
prolonged intense sports training or other increased loads (as an anabolic and adaptogen) to increase performance, endurance and reduce fatigue
exogenous constitutional obesity.

Oral solution.

Regardless of food intake.

The daily dose is dependent on body weight and age:

0 to 6 months recommended 50 mg/kg, 6 months – 1 year 100 mg/kg, 1 to 5 years – 1000 mg/day. Older than 5 years 2000 mg/day. Adults 2-4 g depending on disease severity and doctor’s recommendations.

Postinfarction angina – 2-6 g per day (10 to 30 ml of solution) prescribed by a physician.

Karnilev can be drunk directly or diluted furhter in water or fruit juices. 1 months is the duration of treatment.

Adults with the syndrome of anorexia nervosa – 2 g 2 times/day. Duration of treatment: 1 – 2 months.

For appetite stimulation and weight gain in patients with chronic gastritis with decreased secretion and chronic pancreatitis with exocrine insufficiency single dose is 500 mg 2 times/day. Duration of treatment: 1 – 1.5 months.

Treatment of skin diseases single dose is 1 g of 2 times/day. Duration of treatment: 2-4 weeks.

Long-term physical activity 1-2 g 2-3 times/day. 30 minutes before breakfast and lunch.

Newborn 30 minutes before feeding in a single dose (2-5 drops), 2 times/day, daily dose – 50-100 mg/kg. For the newborns from the first day of life, or 5^th day, which have suffered birth injury and asphyxia, duration of treatment 2-6 weeks.

Composition